Announcing the Use of Gunze’s Meniscal Repair Biodegradable Scaffolds for a Clinical Trial to Improve the Outcome of Medial Meniscal Injury Patients at Osaka Medical and Pharmaceutical University

OSAKA, Japan--(BUSINESS WIRE)--#QOL--Gunze Limited (Headquarters: Osaka, Japan, President: Toshiyasu Saguchi) [TOKYO:3002] is pleased to announce…

DYXnet Spares No Effort to Fulfill Its Corporate Social Responsibility by Donating Social Enterprise Mooncakes to The Elderly Served by Tung Wah Group of Hospitals

HONG KONG SAR - Media OutReach - 16 September 2021 - Caring for the community to uphold corporate…

Razer Cash Payments for Shopee Purchases Available at KK Super Mart

Razer Merchant Services (RMS) enables Razer Cash (cash-over-counter) payments for Shopee’s users at 540 KK…

Daehan Rehabilitation Hospital Putrajaya Offers Post Covid-19 Rehabilitation Like No Other

KUALA LUMPUR, MALAYSIA - Media OutReach - 16September 2021 - "Twenty percent of patients recovering from COVID-19 will now require…

SolarWinds Strengthens International Footprint by Opening South Korean Entity

Company appoints new country manager, marks investment and commitment to valued customers and channel Partners…

TechInsights’ New Mobile Application Putting Semiconductor Analysis in Your Pocket

Ottawa, ON - News Direct - 16 September 2021 - TechInsights announces their new mobile application,…

Western Union Expands with Suhyup Bank in South Korea

Customers Can Now Send Western Union Money Transfers from Suhyup Bank Locations Across the Country…

Vicarious Surgical Business Combination Approved; Stock to Begin Trading on the New York Stock Exchange as “RBOT”

Vicarious Surgical to debut on NYSE as a disruptive next-generation surgical robotics company Approximately $220…

Paul Browning’s Role Expands Globally to Strengthen Mitsubishi Power and Drive the Energy Transition

Named CEO of Energy Transition & Power in the Americas Named Chairman of the Board,…

Takeda’s EXKIVITY™ (mobocertinib) Approved by U.S. FDA as the First Oral Therapy Specifically Designed for Patients with EGFR Exon20 Insertion+ NSCLC

? Approval based on Phase 1/2 trial results, which demonstrated clinically meaningful responses with a…